Among the protein kinases enabling tau modification by phosphorylation, glycogen synthase kinase-3β (GSK-3β), a serine-threonine kinase found to be active in AD patients’ brain [22], has received a great deal of attention. The gene discussed is MAPT; the disease is Alzheimer disease.